Toll Free: 1-888-928-9744
Published: Nov, 2014 | Pages:
26 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Io Therapeutics, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'Io Therapeutics, Inc. - Product Pipeline Review - 2014', provides an overview of the Io Therapeutics, Inc.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Io Therapeutics, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Io Therapeutics, Inc. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Io Therapeutics, Inc.'s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Io Therapeutics, Inc.'s pipeline products Reasons to buy - Evaluate Io Therapeutics, Inc.'s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Io Therapeutics, Inc. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Io Therapeutics, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Io Therapeutics, Inc. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Io Therapeutics, Inc. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Io Therapeutics, Inc. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 3 List of Figures 3 Io Therapeutics, Inc. Snapshot 4 Io Therapeutics, Inc. Overview 4 Key Information 4 Key Facts 4 Io Therapeutics, Inc. - Research and Development Overview 5 Key Therapeutic Areas 5 Io Therapeutics, Inc. - Pipeline Review 7 Pipeline Products by Stage of Development 7 Pipeline Products - Monotherapy 8 Io Therapeutics, Inc. - Pipeline Products Glance 9 Io Therapeutics, Inc. - Clinical Stage Pipeline Products 9 Phase II Products/Combination Treatment Modalities 9 Phase I Products/Combination Treatment Modalities 10 Io Therapeutics, Inc. - Early Stage Pipeline Products 11 Preclinical Products/Combination Treatment Modalities 11 Io Therapeutics, Inc. - Drug Profiles 12 IRX-4204 12 Product Description 12 Mechanism of Action 12 R&D Progress 12 IRX-4310 14 Product Description 14 Mechanism of Action 14 R&D Progress 14 IRX-5183 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 Small Molecule for Undisclosed Indication 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 Io Therapeutics, Inc. - Pipeline Analysis 17 Io Therapeutics, Inc. - Pipeline Products by Target 17 Io Therapeutics, Inc. - Pipeline Products by Route of Administration 18 Io Therapeutics, Inc. - Pipeline Products by Molecule Type 19 Io Therapeutics, Inc. - Pipeline Products by Mechanism of Action 20 Io Therapeutics, Inc. - Recent Pipeline Updates 21 Io Therapeutics, Inc. - Dormant Projects 22 Io Therapeutics, Inc. - Discontinued Pipeline Products 23 Discontinued Pipeline Product Profiles 23 IRX-4204 23 IRX-4310 23 Io Therapeutics, Inc. - Locations And Subsidiaries 24 Head Office 24 Appendix 25 Methodology 25 Coverage 25 Secondary Research 25 Primary Research 25 Expert Panel Validation 25 Contact Us 26 Disclaimer 26
List of Tables Io Therapeutics, Inc., Key Information 4 Io Therapeutics, Inc., Key Facts 4 Io Therapeutics, Inc. - Pipeline by Indication, 2014 6 Io Therapeutics, Inc. - Pipeline by Stage of Development, 2014 7 Io Therapeutics, Inc. - Monotherapy Products in Pipeline, 2014 8 Io Therapeutics, Inc. - Phase II, 2014 9 Io Therapeutics, Inc. - Phase I, 2014 10 Io Therapeutics, Inc. - Preclinical, 2014 11 Io Therapeutics, Inc. - Pipeline by Target, 2014 17 Io Therapeutics, Inc. - Pipeline by Route of Administration, 2014 18 Io Therapeutics, Inc. - Pipeline by Molecule Type, 2014 19 Io Therapeutics, Inc. - Pipeline Products by Mechanism of Action, 2014 20 Io Therapeutics, Inc. - Recent Pipeline Updates, 2014 21 Io Therapeutics, Inc. - Dormant Developmental Projects,2014 22 Io Therapeutics, Inc. - Discontinued Pipeline Products, 2014 23
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.